EP3518916
Title:
COMPOSITION COMPRISING AT LEAST ONE WATER-SOLUBLE PHARMACEUTICALLY ACCEPTABLE SALT OF ELAFIBRANOR HAVING IMPROVED INTESTINAL ABSORPTION
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP3518916
WO Application Number:
EP2017074701
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17777046.8
WO Publication Number:
WO2018060372
EPO Publication Language:
French
SPC Number:
First Applicant Residence Country:
France (FR)
Publications:
Dates
Filing date:
28/09/2017
Grant date:
07/07/2021
EP Publication Date:
07/08/2019
WO Publication Date:
05/04/2018
Claims Translations Received Date:
Claims Translation B1 Received Date:
29/09/2021
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/10/2024
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
07/07/2021
EP B1 Publication Date:
07/07/2021
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
29/09/2021
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
27/09/2037
Lapsed By Expiration Date:
Patent Validated Date:
14/10/2021
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
07/07/2021
Name:
Nashpharm
Address:
18 avenue Bellevue, 06270 Villeneuve Loubet, France (FR)